| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
2 |
| issn |
1544-2241
1544-1873 |
| issueIdentifier |
1 |
| pageRange |
1-2 |
| publicationName |
Current Osteoporosis Reports |
| startingPage |
1 |
| bibliographicCitation |
Silverman SL. Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture. Curr Osteoporos Rep. 2009 Mar;7(1):1–2. doi: 10.1007/s11914-009-0001-8. PMID: 19239822. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_565d81176e72ba822ada840adf0cd620 |
| date |
2009-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1007/s11914-009-0001-8
https://pubmed.ncbi.nlm.nih.gov/19239822 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1544-2241
https://portal.issn.org/resource/ISSN/1544-1873
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32518 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8026 |